美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=SITAGLIPTIN"
符合检索条件的记录共 51 条
共 3 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
SITAGLIPTIN PHOSPHATE 202473 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 25MG BASE No No 2012/10/10 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202473 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 50MG BASE No No 2012/10/10 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202473 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL EQ 100MG BASE No No 2012/10/10 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 25MG No No 2013/04/11 (TA) -- SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 50MG No No 2013/04/11 (TA) -- SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202423 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 100MG No No 2013/04/11 (TA) -- SUN PHARMA GLOBAL None (Tentative Approval)
SITAGLIPTIN; METFORMIN HYDROCHLORIDE 202388 001 ANDA SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET; ORAL 50MG; 500MG No No 2013/07/30 (TA) -- SANDOZ INC None (Tentative Approval)
SITAGLIPTIN; METFORMIN HYDROCHLORIDE 202388 002 ANDA SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET; ORAL 50MG; 1000MG No No 2013/07/30 (TA) -- SANDOZ INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 001 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 25MG No No 2014/02/18 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 002 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 50MG No No 2014/02/18 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202425 003 ANDA SITAGLIPTIN PHOSPHATE TABLET; ORAL 100MG No No 2014/02/18 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN; METFORMIN HYDROCHLORIDE 202426 001 ANDA SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET; ORAL 50MG; 500MG No No 2014/03/10 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN; METFORMIN HYDROCHLORIDE 202426 002 ANDA SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET; ORAL 50MG; 1000MG No No 2014/03/10 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 001 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 25MG No No 2014/04/15 (TA) -- WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 002 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 50MG No No 2014/04/15 (TA) -- WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202327 003 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 100MG No No 2014/04/15 (TA) -- WATSON LABS INC None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 001 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 25MG No No 2015/02/23 (TA) -- TEVA PHARMS USA None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 002 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 50MG No No 2015/02/23 (TA) -- TEVA PHARMS USA None (Tentative Approval)
SITAGLIPTIN PHOSPHATE 202487 003 ANDA SITAGLIPTIN PHOSPHATE TABLET;ORAL 100MG No No 2015/02/23 (TA) -- TEVA PHARMS USA None (Tentative Approval)
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE 204144 001 ANDA METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE TABLET, EXTENDED RELEASE;ORAL 500MG; EQ 50MG BASE No No 2015/04/21 (TA) -- ANCHEN PHARMS None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database